HT94252510537
Project Grant
Overview
Grant Description
IDENTIFICATION AND ASSESSMENT OF TARGETS FOR IMMUNOTHERAPY IN NF2-ASSOCIATED SCHWANNOMATOSIS
Funding Goals
NEUROFIBROMATOSIS RESEARCH PROGRAM AWARD MECHANISM: INVESTIGATOR-INITIATED RESEARCH AWARD - FUNDING LEVEL 2 - OPTIONAL QUALIFIED COLLABORATOR
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Tampa,
Florida
336129416
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have decreased 100% from $968,875 to $0.
H. Lee Moffitt Cancer Center And Research Institute Hospital was awarded
Project Grant HT94252510537
from Defense Health Agency in July 2025 with work to be completed primarily in Tampa Florida United States.
The grant
has a duration of 3 years and
was awarded through assistance program 12.420 Military Medical Research and Development.
The Project Grant was awarded through grant opportunity CDMRP Neurofibromatosis Investigator-Initiated Research Program.
Status
(Ongoing)
Last Modified 6/11/25
Period of Performance
7/1/25
Start Date
6/30/28
End Date
Funding Split
$0.0
Federal Obligation
$0.0
Non-Federal Obligation
$0.0
Total Obligated
Additional Detail
Award ID FAIN
HT94252510537
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
DVHKP4N619V9
Awardee CAGE
1X4B9
Performance District
FL-15
Senators
Marco Rubio
Rick Scott
Rick Scott
Modified: 6/11/25